MRNA — Moderna, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1682852 ·
Last close
$192.57
Market Cap
$76.88B
52W High
$208.90
52W Low
$22.28
ADV30
29,311,198
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 389,000,000 | -566,000,000 | -1,388,000,000 | -1,343,000,000 | 11,488,000,000 | 1,908,000,000 | 4,080,000,000 |
| Dec 2025 | 676,000,000 | 224,000,000 | -857,000,000 | -826,000,000 | 12,338,000,000 | 2,595,000,000 | 3,688,000,000 |
| Sep 2025 | 1,002,000,000 | 795,000,000 | -260,000,000 | -200,000,000 | 12,135,000,000 | 1,132,000,000 | 2,805,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,466,000,000
Investing CF
$1,140,000,000
Financing CF
$606,000,000
CapEx
$-137,000,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-7.99
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$5,880,000,000
Inventory
$146,000,000
Receivables
$182,000,000
ST Investments
$3,297,000,000
EBIT TTM
$-3,112,000,000
Pretax Income TTM
$-3,138,000,000
Interest Exp TTM
$26,000,000
Analysts
19
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,228,000,000
EBITDA
$-2,195,000,064
Free Cash Flow
$299,249,984
Enterprise Value
$53,626,990,592
Total Cash
$5,137,999,872
Total Debt
$1,287,000,064
Shares Out
399,235,889
Trailing EPS
$-7.98
Book Value
$16.95
ROE
-39.0%
ROA
-13.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,922,000,000 | -3,074,000,000 | -2,822,000,000 | 12,338,000,000 | 3,688,000,000 | 8,650,000,000 | -1,873,000,000 |
| Dec 2024 | 3,199,000,000 | -3,945,000,000 | -3,561,000,000 | 14,142,000,000 | 3,241,000,000 | 10,901,000,000 | -3,004,000,000 |
| Dec 2023 | 6,754,000,000 | -4,239,000,000 | -4,714,000,000 | 18,426,000,000 | 4,572,000,000 | 13,854,000,000 | -3,118,000,000 |
| Dec 2022 | 18,875,000,000 | 9,420,000,000 | 8,362,000,000 | 25,858,000,000 | 6,735,000,000 | 19,123,000,000 | 4,981,000,000 |
TTM Snapshot
Revenues TTM
$7,165,000,000
NetIncome TTM
$-3,545,000,000
OpCashFlow TTM
$0
Assets (Latest)
$12,338,000,000
Forward EPS
$-4.47
Max Pain — expiry 2026-10-09 (volume-derived — Yahoo OI feed degraded)
max pain strike: $187.50 · spot: $192.57 · call volume: 3,330 · put volume: 5,147
Expected Move to 2026-10-09:
±$19.90
(10.33%) —
implied range
$172.67 –
$212.47
· ATM straddle on $192.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ARGX | ARGENX SE | $59.63B | $958.91 | — |
| RVMD | Revolution Medicines, Inc. | $43.99B | $205.26 | — |
| BIIB | BIOGEN INC. | $33.37B | $225.88 | — |
| GILD | GILEAD SCIENCES, INC. | $184.82B | $149.05 | — |
| AMGN | AMGEN INC | $227.88B | $421.51 | — |
News headlines (Yahoo Finance, 1h cache)
Citi delivers major verdict after Moderna’s remarkable 703% run
2026-09-30 22:17 · Yahoo
Moderna, Cerebras, Jabil, HPE, Cal-Maine, Mattel, and More Stocks That Explain Today’s Market
2026-09-30 21:09 · Yahoo
Why Moderna (MRNA) Shares Are Falling Today
2026-09-30 21:01 · Yahoo
This Analyst Just Downgraded Moderna Stock. Here's Why.
2026-09-30 20:40 · Yahoo
Citi Downgrades Moderna Stock, Warning $80 Billion Valuation Asks Too Much of Cancer Pipeline
2026-09-30 20:15 · Yahoo
After Moderna's Dizzying Rally, It's Time To Sell, Says Analyst
2026-09-30 20:11 · Yahoo
Moderna Stock Slumps as Citi Says It’s Time to Sell After 500% Rally This Year
2026-09-30 19:31 · Yahoo
Prediction: Moderna Stock Will Soar 100% by 2030
2026-09-30 18:25 · Yahoo
Moderna and Fair Isaac: The Best and Worst S&P 500 Stocks for the Third Quarter
2026-09-30 15:28 · Yahoo
Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat
2026-09-30 13:42 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.